NDC 71335-1007-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71335-1007
- Requested NDC
- 71335-1007-01
- Package NDCs from labels
- 71335-1007-1, 71335-1007-2, 71335-1007-3, 71335-1007-4, 71335-1007-5, 71335-1007-6, 71335-1007-7, 71335-1007-8, 71335-1007-9, 71335-1007-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-04-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-1007-1 | Gabapentin | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 71335-1007-2 | Gabapentin | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 7 | |
| 71335-1007-3 | Gabapentin | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 71335-1007-4 | Gabapentin | 180 in 1 BOTTLE | TABLET, FILM COATED | 180 | 7 | |
| 71335-1007-5 | Gabapentin | 120 in 1 BOTTLE | TABLET, FILM COATED | 120 | 7 | |
| 71335-1007-6 | Gabapentin | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 7 | |
| 71335-1007-7 | Gabapentin | 84 in 1 BOTTLE | TABLET, FILM COATED | 84 | 7 | |
| 71335-1007-8 | Gabapentin | 112 in 1 BOTTLE | TABLET, FILM COATED | 112 | 7 | |
| 71335-1007-9 | Gabapentin | 135 in 1 BOTTLE | TABLET, FILM COATED | 135 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-1007 | GABAPENTIN TABLET, FILM COATED [BRYANT RANCH PREPACK] | 7 | Current NDC, Legacy NDC, 9 package rows | 20240410_47f2a06f-4eac-4dca-aa2a-a36dd4daaea0.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71335-1007-1 | EA - Each | 71335-1007 | f2b25697-1f03-47d4-94fe-7a0995686db5 | 1 | 2021-07-15 |
| 71335-1007-2 | EA - Each | 71335-1007 | b791aa29-3ce5-4638-b5e7-da655acfdcb7 | 1 | 2021-07-15 |
| 71335-1007-3 | EA - Each | 71335-1007 | 52c93a4e-79e2-4248-9daf-9bd9eada6690 | 1 | 2019-09-05 |
| 71335-1007-5 | EA - Each | 71335-1007 | 9f3e7833-80d9-47e1-a2f1-b44d11da9d70 | 1 | 2019-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LUMINOUS EYE CORRECTOR SPF 41 - TAN | TITANIUM DIOXIDE, ZINC OXIDE | Drmtlgy, LLC | 5c5aad09-9f93-4634-8db1-c67570b38b2b | 2026-05-04 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | Major Pharmaceuticals | 999f3685-2eac-467e-bed2-1d0c36aaf0ed | 2026-05-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 180b99a5-7d3d-4ee5-a0cc-1ae0ede646ee | 2026-05-04 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 35da078b-0da0-4757-a6c4-a9144c37e8e1 | 2026-05-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 38119f2e-33b3-4c3c-99b7-9335d8d280d4 | 2026-05-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | b8b7e045-a7fe-8539-e053-2a95a90a40f8 | 2026-05-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St Mary's Medical Park Pharmacy | de990f96-96bc-406d-e053-2995a90abebb | 2026-05-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Blue Lizard Sport SPF 50 Sunscreen | OCTISALATE AND TITANIUM DIOXIDE AND ZINC OXIDE | Crown Laboratories | 4955fa1c-789d-4f42-af75-70223310644a | 2026-05-01 | Warnings | 15FIX9V2JP |
| Blue Lizard Kids SPF 50 Sunscreen | OCTISALATE AND TITANIUM DIOXIDE AND ZINC OXIDE | Crown Laboratories | ba4ae906-48c0-8384-e053-2995a90afb91 | 2026-05-01 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 4cb26d6e-7963-4fe5-903e-ab5180545066 | 2026-05-01 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Dior Backstage Glow-Up Skin Tint Tinted Moisturizer SPF 20 2CR Cool Rosy | OCTISALATE, TITANIUM DIOXIDE | Parfums Christian Dior | 6831832a-e52e-43ea-899f-f5d44bea5a94 | 2026-04-30 | Warnings | 15FIX9V2JP |
| Tru Skin Rituals SPF 25 | TITANIUM DIOXIDE, ZINC OXIDE | Spa de Soleil | f725cd5c-999e-2393-e053-6394a90a09dc | 2026-04-30 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | 100ff86c-56a8-4770-9db3-b9bc6b1bd2f7 | 2026-04-30 | Warnings, Adverse reactions | 6CW7F3G59X |
| TiZO2 | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals Ltd. | 509cad98-0321-2a0a-e063-6294a90a6ea9 | 2026-04-29 | Warnings | 15FIX9V2JP |
| TiZO2 | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals Ltd. | 509d7206-0cc1-c997-e063-6294a90a89e0 | 2026-04-29 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | d22ed424-f365-44ca-8ef9-a08255a90ae8 | 2026-04-29 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| JMSOLUTION SKIN BOOST NIACINAMIDE SUNSCREEN | HOMOSALATE, OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE | GPNY CORP | 211dea04-faad-8ffc-e063-6294a90a8d68 | 2026-04-29 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | e3429322-c442-4146-bb68-bcc3a8d01552 | 2026-04-29 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | 2625c0ef-5295-41de-9e81-88001a6cbecc | 2026-04-29 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | 6ecf5114-2ddc-4025-a36d-1884702dc22a | 2026-04-29 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.